Anti-spike versus anti-nucleocapsid IgG.
- Tamara Elliott (13905958)
- Hannah M. Cheeseman (2741536)
- Abbey B. Evans (2741527)
- Suzanne Day (4401046)
- Leon R. McFarlane (7795319)
- Jessica O’Hara (13905961)
- Mohini Kalyan (13905964)
- Fahimah Amini (10305360)
- Tom Cole (202973)
- Alan Winston (316046)
- Sarah Fidler (76851)
- Katrina M. Pollock (13905967)
- James A. Harker (4474759)
- Robin J. Shattock (6630200)
Publication date
October 2022
DOI Publisher
Public Library of Science (PLoS)Abstract
2a. Baseline (pre-vaccination) anti-S and anti-N IgG in COVID-19 experienced (blue, n = 37) and COVID naïve (red, n = 38) participants as measured by ELISA. 2b. Anti-S and anti-N IgG two weeks following the 2nd UK authorised vaccine dose in COVID-19 experienced (n = 36) and naïve (n = 33). LOD; level of detection.</p
Add to ORKG